25 November 2017
News and Views
Links and Services
The latest publication of the American Journal of Gastroenterology reviews the efficacy of 5-aminosalicylates in Crohn's disease.
Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors